Browsing Tag
National Health Service
6 posts
Tempus (Nasdaq: TEM) gains real-world NHS evidence for Paige Prostate AI, but scale-up still depends on economics
Prospective NHS deployment strengthens the clinical case for Tempus AI’s digital pathology portfolio, although cost effectiveness, infrastructure readiness and commercial conversion remain unproven.
Genedrive partners with Thermo Fisher as $GDR targets high-throughput NHS testing
Genedrive has signed a development agreement with Thermo Fisher Scientific for a high-throughput CYP2C19 assay, potentially expanding its stroke-testing business from hospital wards into central NHS genomic laboratories.
Can Toscafund finally take Spire Healthcare private after years of takeover frustration?
Find out how Spire Healthcare’s Toscafund deadline extension could reshape SPI stock sentiment, UK private hospital M&A and takeover risk.
UK pharmacy funding boost puts high street healthcare at centre of NHS access strategy
GP access pressure is pushing care onto the high street. The UK’s £340m pharmacy boost tests whether local pharmacies can ease NHS strain.
Golders Green terror attack: Why Downing Street is moving from condemnation to enforcement
Jewish fear is now a Downing Street security test. Golders Green forces Britain to confront antisemitism, policing and hostile-state threats.
Why Hims & Hers Health’s decision to offer Grail’s Galleri test looks riskier after the U.K. NHS trial miss
Grail’s Galleri cancer test missed a major U.K. NHS trial goal just as Hims & Hers Health began offering it. Find out what this means for investors and screening strategy.